SCHEMBL2237577

SCHEMBL2237577

CCCOC(N)=S.CCCOC(N)=S

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.38
CA1 P00915 6/20 0.37
CA2 P00918 6/20 0.37
CA12 O43570 5/20 0.37
CA9 Q16790 5/20 0.37
HCAR2 Q8TDS4 1/20 0.34
ALDH1A1 P00352 3/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
LMNA P02545 1/20 0.32
ESR1 P03372 1/20 0.31
CHRM1 P11229 1/20 0.31
TSHR P16473 1/20 0.31
SLC6A2 P23975 1/20 0.31
KDR P35968 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
PPM1B O75688 1/20 0.31
PTPN1 P18031 1/20 0.31
PPP1CC P36873 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2746578 1.00
Hydrochloric Acid SCHEMBL11088219 0.97
Propane SCHEMBL28432693 0.97 HPGD (0.36) HPGDCA1CA2CA12CA9
SCHEMBL6298110 0.97 HPGD (0.36) HPGDCA1CA2CA12CA9
SCHEMBL2126842 0.97 HPGD (0.36) HPGDCA1CA2CA12CA9
SCHEMBL701336 0.97 HPGD (0.36) HPGDCA1CA2CA12CA9
SCHEMBL3190229 0.97 HPGD (0.36) HPGDCA1CA2CA12CA9
SCHEMBL27690894 0.95 HPGD (0.39) HPGDCA1CA2CA12CA9
SCHEMBL10767942 0.95 HPGD (0.39) HPGDCA1CA2CA12CA9
SCHEMBL6564983 0.92 HPGD (0.38) HPGDCA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114014277-B Copper indium selenium nanocrystal, nano film, preparation method of copper indium selenium nanocrystal and preparation method of nano film and electronic device 广东省科学院半导体研究所 2023-04-11 CN claimed
CN-114014277-A Copper indium selenium nanocrystal, nano film, preparation method of copper indium selenium nanocrystal and preparation method of nano film and electronic device 广东省科学院半导体研究所 2022-02-08 CN claimed
CN-113430375-A Method for separating low-valence ferrovanadium-chromium solution 四川大学 2021-09-24 CN claimed
US-6858568-B2 Metal lubricants containing a bridge complex MEC INTERNATIONAL CORPORATION (JP) 2005-02-22 US claimed
EP-1307239-A4 RADIOPHARMACEUTICAL FOR DIAGNOSTIC IMAGING CONTAINING A TECHNETIUM-99M NITRIDE HETEROCOMPLEX NIHON MEDIPHYSICS CO LTD (JP) 2005-01-26 EP claimed
US-20040018147-A1 Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex NIHON MEDI-PHYSICS CO., LTD. (JP) 2004-01-29 US claimed
EP-1307239-A1 RADIOPHARMACEUTICAL FOR DIAGNOSTIC IMAGING CONTAINING A TECHNETIUM-99M NITRIDE HETEROCOMPLEX Nihon Medi-Physics Co., Ltd. (JP) 2003-05-07 EP claimed
CN-1407854-A N-aryi-uracile-based herbicides BAYER AG (DE) 2003-04-02 CN claimed
US-20020123435-A1 Metal lubricants containing a bridge complex MEC INTERNATIONAL CORPORATION 2002-09-05 US claimed
WO-2002009771-A1 RADIOPHARMACEUTICAL FOR DIAGNOSTIC IMAGING CONTAINING A TECHNETIUM-99M NITRIDE HETEROCOMPLEX NIHON MEDI-PHYSICS CO., LTD. (JP) 2002-02-07 WO claimed
JP-10076240-A None JP disclosed
CN-117980437-A Solvent-free quantum dot composition, method of preparing the same, cured film, color filter and display device including the same 韩松化学株式会社 2024-05-03 CN disclosed
CN-116783267-A Solvent-free quantum dot composition, preparation method thereof, cured film comprising solvent-free quantum dot composition, color filter comprising solvent-free quantum dot composition, and display device comprising solvent-free quantum dot composition 韩松化学株式会社 2023-09-19 CN disclosed
CN-116157494-A Phosphorus-free oil-soluble molybdenum complexes as high temperature scale inhibitors 埃科莱布美国股份有限公司 2023-05-23 CN disclosed
CN-116057155-A Phosphorus-free oil-soluble molybdenum complex for high-temperature naphthenic acid corrosion inhibition 埃科莱布美国股份有限公司 2023-05-02 CN disclosed
WO-1994012034-A1 DURABLE ANTI-MICROBIAL AGENTS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1994-06-09 WO disclosed
US-5055211-A Lubricating oil containing a mixed ligand metal complex and a metal thiophosphate EXXON RESEARCH AND ENGINEERING COMPANY (US) 1991-10-08 US disclosed
EP-0007718-B1 OXIDATION PROCESS USING METAL NITRO COMPLEX ALLIED CORPORATION (US) 1983-09-21 EP disclosed
US-4191696-A Oxidation process using metal nitro complex ALLIED CHEMICAL CORPORATION (US) 1980-03-04 US disclosed
EP-0007718-A1 Oxidation process using metal nitro complex ALLIED CORPORATION (US) 1980-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040018147-A1 Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex SHBG, TNNT2, TNNI3 HPGD 785/4885CA1 3592/4885CA2 3195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.